Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Identifieur interne : 001138 ( PubMed/Corpus ); précédent : 001137; suivant : 001139

RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Auteurs : Jane A C. Wilson ; Natalie A. Prow ; Wayne A. Schroder ; Jonathan J. Ellis ; Helen E. Cumming ; Linden J. Gearing ; Yee Suan Poo ; Adam Taylor ; Paul J. Hertzog ; Francesca Di Giallonardo ; Linda Hueston ; Roger Le Grand ; Bing Tang ; Thuy T. Le ; Joy Gardner ; Suresh Mahalingam ; Pierre Roques ; Phillip I. Bird ; Andreas Suhrbier

Source :

RBID : pubmed:28207896

English descriptors

Abstract

Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.

DOI: 10.1371/journal.ppat.1006155
PubMed: 28207896

Links to Exploration step

pubmed:28207896

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</title>
<author>
<name sortKey="Wilson, Jane A C" sort="Wilson, Jane A C" uniqKey="Wilson J" first="Jane A C" last="Wilson">Jane A C. Wilson</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schroder, Wayne A" sort="Schroder, Wayne A" uniqKey="Schroder W" first="Wayne A" last="Schroder">Wayne A. Schroder</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ellis, Jonathan J" sort="Ellis, Jonathan J" uniqKey="Ellis J" first="Jonathan J" last="Ellis">Jonathan J. Ellis</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cumming, Helen E" sort="Cumming, Helen E" uniqKey="Cumming H" first="Helen E" last="Cumming">Helen E. Cumming</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gearing, Linden J" sort="Gearing, Linden J" uniqKey="Gearing L" first="Linden J" last="Gearing">Linden J. Gearing</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poo, Yee Suan" sort="Poo, Yee Suan" uniqKey="Poo Y" first="Yee Suan" last="Poo">Yee Suan Poo</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Adam" sort="Taylor, Adam" uniqKey="Taylor A" first="Adam" last="Taylor">Adam Taylor</name>
<affiliation>
<nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hertzog, Paul J" sort="Hertzog, Paul J" uniqKey="Hertzog P" first="Paul J" last="Hertzog">Paul J. Hertzog</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Di Giallonardo, Francesca" sort="Di Giallonardo, Francesca" uniqKey="Di Giallonardo F" first="Francesca" last="Di Giallonardo">Francesca Di Giallonardo</name>
<affiliation>
<nlm:affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hueston, Linda" sort="Hueston, Linda" uniqKey="Hueston L" first="Linda" last="Hueston">Linda Hueston</name>
<affiliation>
<nlm:affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Le Grand, Roger" sort="Le Grand, Roger" uniqKey="Le Grand R" first="Roger" last="Le Grand">Roger Le Grand</name>
<affiliation>
<nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tang, Bing" sort="Tang, Bing" uniqKey="Tang B" first="Bing" last="Tang">Bing Tang</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Le, Thuy T" sort="Le, Thuy T" uniqKey="Le T" first="Thuy T" last="Le">Thuy T. Le</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gardner, Joy" sort="Gardner, Joy" uniqKey="Gardner J" first="Joy" last="Gardner">Joy Gardner</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mahalingam, Suresh" sort="Mahalingam, Suresh" uniqKey="Mahalingam S" first="Suresh" last="Mahalingam">Suresh Mahalingam</name>
<affiliation>
<nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Roques, Pierre" sort="Roques, Pierre" uniqKey="Roques P" first="Pierre" last="Roques">Pierre Roques</name>
<affiliation>
<nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bird, Phillip I" sort="Bird, Phillip I" uniqKey="Bird P" first="Phillip I" last="Bird">Phillip I. Bird</name>
<affiliation>
<nlm:affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Suhrbier, Andreas" sort="Suhrbier, Andreas" uniqKey="Suhrbier A" first="Andreas" last="Suhrbier">Andreas Suhrbier</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28207896</idno>
<idno type="pmid">28207896</idno>
<idno type="doi">10.1371/journal.ppat.1006155</idno>
<idno type="wicri:Area/PubMed/Corpus">001138</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001138</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</title>
<author>
<name sortKey="Wilson, Jane A C" sort="Wilson, Jane A C" uniqKey="Wilson J" first="Jane A C" last="Wilson">Jane A C. Wilson</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schroder, Wayne A" sort="Schroder, Wayne A" uniqKey="Schroder W" first="Wayne A" last="Schroder">Wayne A. Schroder</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ellis, Jonathan J" sort="Ellis, Jonathan J" uniqKey="Ellis J" first="Jonathan J" last="Ellis">Jonathan J. Ellis</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cumming, Helen E" sort="Cumming, Helen E" uniqKey="Cumming H" first="Helen E" last="Cumming">Helen E. Cumming</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gearing, Linden J" sort="Gearing, Linden J" uniqKey="Gearing L" first="Linden J" last="Gearing">Linden J. Gearing</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poo, Yee Suan" sort="Poo, Yee Suan" uniqKey="Poo Y" first="Yee Suan" last="Poo">Yee Suan Poo</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Adam" sort="Taylor, Adam" uniqKey="Taylor A" first="Adam" last="Taylor">Adam Taylor</name>
<affiliation>
<nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hertzog, Paul J" sort="Hertzog, Paul J" uniqKey="Hertzog P" first="Paul J" last="Hertzog">Paul J. Hertzog</name>
<affiliation>
<nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Di Giallonardo, Francesca" sort="Di Giallonardo, Francesca" uniqKey="Di Giallonardo F" first="Francesca" last="Di Giallonardo">Francesca Di Giallonardo</name>
<affiliation>
<nlm:affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hueston, Linda" sort="Hueston, Linda" uniqKey="Hueston L" first="Linda" last="Hueston">Linda Hueston</name>
<affiliation>
<nlm:affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Le Grand, Roger" sort="Le Grand, Roger" uniqKey="Le Grand R" first="Roger" last="Le Grand">Roger Le Grand</name>
<affiliation>
<nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tang, Bing" sort="Tang, Bing" uniqKey="Tang B" first="Bing" last="Tang">Bing Tang</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Le, Thuy T" sort="Le, Thuy T" uniqKey="Le T" first="Thuy T" last="Le">Thuy T. Le</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gardner, Joy" sort="Gardner, Joy" uniqKey="Gardner J" first="Joy" last="Gardner">Joy Gardner</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mahalingam, Suresh" sort="Mahalingam, Suresh" uniqKey="Mahalingam S" first="Suresh" last="Mahalingam">Suresh Mahalingam</name>
<affiliation>
<nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Roques, Pierre" sort="Roques, Pierre" uniqKey="Roques P" first="Pierre" last="Roques">Pierre Roques</name>
<affiliation>
<nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bird, Phillip I" sort="Bird, Phillip I" uniqKey="Bird P" first="Phillip I" last="Bird">Phillip I. Bird</name>
<affiliation>
<nlm:affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Suhrbier, Andreas" sort="Suhrbier, Andreas" uniqKey="Suhrbier A" first="Andreas" last="Suhrbier">Andreas Suhrbier</name>
<affiliation>
<nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PLoS pathogens</title>
<idno type="eISSN">1553-7374</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Arthritis (virology)</term>
<term>Chikungunya Fever (genetics)</term>
<term>Chikungunya Fever (immunology)</term>
<term>Chikungunya virus</term>
<term>Disease Models, Animal</term>
<term>Granzymes (analysis)</term>
<term>Granzymes (biosynthesis)</term>
<term>Granzymes (immunology)</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Inflammation (virology)</term>
<term>Macaca fascicularis</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Knockout</term>
<term>RNA, Messenger (analysis)</term>
<term>Transcriptome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Granzymes</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Granzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Chikungunya Fever</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Chikungunya Fever</term>
<term>Granzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Arthritis</term>
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chikungunya virus</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Macaca fascicularis</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Knockout</term>
<term>Transcriptome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28207896</PMID>
<DateCreated>
<Year>2017</Year>
<Month>02</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>08</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>08</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1553-7374</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>PLoS pathogens</Title>
<ISOAbbreviation>PLoS Pathog.</ISOAbbreviation>
</Journal>
<ArticleTitle>RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</ArticleTitle>
<Pagination>
<MedlinePgn>e1006155</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1006155</ELocationID>
<Abstract>
<AbstractText>Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT00281294.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Jane A C</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prow</LastName>
<ForeName>Natalie A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schroder</LastName>
<ForeName>Wayne A</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ellis</LastName>
<ForeName>Jonathan J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cumming</LastName>
<ForeName>Helen E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gearing</LastName>
<ForeName>Linden J</ForeName>
<Initials>LJ</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-3508-3056</Identifier>
<AffiliationInfo>
<Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poo</LastName>
<ForeName>Yee Suan</ForeName>
<Initials>YS</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-7159-3961</Identifier>
<AffiliationInfo>
<Affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hertzog</LastName>
<ForeName>Paul J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Giallonardo</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hueston</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Le Grand</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Bing</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Le</LastName>
<ForeName>Thuy T</ForeName>
<Initials>TT</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-9134-0104</Identifier>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gardner</LastName>
<ForeName>Joy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mahalingam</LastName>
<ForeName>Suresh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roques</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1825-1054</Identifier>
<AffiliationInfo>
<Affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bird</LastName>
<ForeName>Phillip I</ForeName>
<Initials>PI</Initials>
<AffiliationInfo>
<Affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suhrbier</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8986-9025</Identifier>
<AffiliationInfo>
<Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>02</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS Pathog</MedlineTA>
<NlmUniqueID>101238921</NlmUniqueID>
<ISSNLinking>1553-7366</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="D053804">Granzymes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2015 May;15(5):519-27</RefSource>
<PMID Version="1">25739878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2014 Dec 18;41(6):960-72</RefSource>
<PMID Version="1">25526309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Mar 28;289(13):9408-17</RefSource>
<PMID Version="1">24505135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2010 Feb 15;207(2):429-42</RefSource>
<PMID Version="1">20123960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Transplant Proc. 1998 Dec;30(8):3972-4</RefSource>
<PMID Version="1">9865265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2014 Nov;88(22):13333-43</RefSource>
<PMID Version="1">25210177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2010 Jul;38(12):e131</RefSource>
<PMID Version="1">20395217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Nov 6;9(3):910-7</RefSource>
<PMID Version="1">25437548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2015 Dec 08;11(12):e1005324</RefSource>
<PMID Version="1">26646986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheum. 2011 Feb;63(2):488-91</RefSource>
<PMID Version="1">21280003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheum. 2012 Nov;64(11):3553-63</RefSource>
<PMID Version="1">22833339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Rev. 2016 Oct;68(4):1110-1142</RefSource>
<PMID Version="1">27677721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Asian Pac J Trop Med. 2013 Aug;6(8):631-4</RefSource>
<PMID Version="1">23790334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Interferon Res. 1990 Jun;10(3):293-8</RefSource>
<PMID Version="1">1696607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5117-22</RefSource>
<PMID Version="1">25848017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Dec 23;8(12):e84695</RefSource>
<PMID Version="1">24376836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Med. 2015 Apr 30;13:102</RefSource>
<PMID Version="1">25976325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Microbiol. 2016 Feb;18(2):168-80</RefSource>
<PMID Version="1">26572694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2012 Jun 15;28(12):1647-9</RefSource>
<PMID Version="1">22543367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Oct 24;8(10):e76412</RefSource>
<PMID Version="1">24204622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2011 Feb 15;186(4):2472-81</RefSource>
<PMID Version="1">21248253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2011 Mar 24;29(15):2803-9</RefSource>
<PMID Version="1">21320541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2008 Apr;9(4):378-87</RefSource>
<PMID Version="1">18345002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Commun. 2016 Feb 19;7:10680</RefSource>
<PMID Version="1">26893169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2004 Sep;103(3):245-59</RefSource>
<PMID Version="1">15464592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2015 Apr 30;11(4):e1004863</RefSource>
<PMID Version="1">25927359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2014 Nov 1;193(9):4634-42</RefSource>
<PMID Version="1">25261479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Nov;82(22):11263-72</RefSource>
<PMID Version="1">18787004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2015 Aug 20;126(8):e1-e10</RefSource>
<PMID Version="1">26124495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Immunol. 2013 Dec;149(3):487-97</RefSource>
<PMID Version="1">24239837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5783-7</RefSource>
<PMID Version="1">8650169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2015 Jan;89(1):581-93</RefSource>
<PMID Version="1">25339772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2009 May 1;25(9):1105-11</RefSource>
<PMID Version="1">19289445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2014 Mar;88(6):3527-47</RefSource>
<PMID Version="1">24403588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Jul 16;274(29):20178-84</RefSource>
<PMID Version="1">10400633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Immunol. 1995 Dec;25(12):3256-62</RefSource>
<PMID Version="1">8566009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1998 Jun;72(6):5146-53</RefSource>
<PMID Version="1">9573286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2015 May 07;9(5):e0003764</RefSource>
<PMID Version="1">25951202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Viral Immunol. 2011 Aug;24(4):265-71</RefSource>
<PMID Version="1">21830898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1996 Apr 1;156(7):2585-90</RefSource>
<PMID Version="1">8786323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Trop Med Rep. 2015 Mar;2(1):13-21</RefSource>
<PMID Version="1">26366337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2015 Jun 15;211(12):1925-35</RefSource>
<PMID Version="1">25635123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biomed Res Int. 2013;2013:973516</RefSource>
<PMID Version="1">24069610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2012 Apr 10;425(2):103-12</RefSource>
<PMID Version="1">22305131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Rheumatol. 2012 May 08;8(7):420-9</RefSource>
<PMID Version="1">22565316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2000 Jul;182(1):206-13</RefSource>
<PMID Version="1">10882599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2009 Jan;37(1):1-13</RefSource>
<PMID Version="1">19033363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2010 May;28(5):511-5</RefSource>
<PMID Version="1">20436464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brief Bioinform. 2013 Mar;14(2):178-92</RefSource>
<PMID Version="1">22517427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2011 Sep;85(17):8709-17</RefSource>
<PMID Version="1">21715498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2013 Jan;14(1):61-71</RefSource>
<PMID Version="1">23160154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 Apr;83(8):3429-35</RefSource>
<PMID Version="1">19176616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2010 Aug 1;185(3):1794-803</RefSource>
<PMID Version="1">20585036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2015 Mar 26;372(13):1231-9</RefSource>
<PMID Version="1">25806915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Aug;84(16):8021-32</RefSource>
<PMID Version="1">20519386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2007 Aug;27(2):240-52</RefSource>
<PMID Version="1">17723216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(1):e4261</RefSource>
<PMID Version="1">19156204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Immunol. 2005 Oct;35(10):2940-8</RefSource>
<PMID Version="1">16208762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2010 May 15;184(10):5914-27</RefSource>
<PMID Version="1">20404278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16038-43</RefSource>
<PMID Version="1">21896755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013 Jan;9(1):e1003118</RefSource>
<PMID Version="1">23300459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2000 Oct 1;165(7):3966-9</RefSource>
<PMID Version="1">11034405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbiol Immunol. 2012 Feb;56(2):134-8</RefSource>
<PMID Version="1">22188545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Biosci. 2015 Apr 18;5:17</RefSource>
<PMID Version="1">25960866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2000 Jan;74(2):1029-32</RefSource>
<PMID Version="1">10623769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2013 Oct 16;32(20):2751-63</RefSource>
<PMID Version="1">24065129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2014 Apr;88(8):4180-94</RefSource>
<PMID Version="1">24478443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Mol Med. 2012 Apr;4(4):330-43</RefSource>
<PMID Version="1">22389221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol Res. 2015;2015:272359</RefSource>
<PMID Version="1">26199948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423</RefSource>
<PMID Version="1">24069479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2014 Jun;88(12):6862-72</RefSource>
<PMID Version="1">24696480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2015 Feb 19;11(2):e1004649</RefSource>
<PMID Version="1">25695775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2011 Jul 1;204(1):115-23</RefSource>
<PMID Version="1">21628665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6</RefSource>
<PMID Version="1">23203888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2015 Oct 14;90(1):92-102</RefSource>
<PMID Version="1">26468529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2013 Jan 1;190(1):259-69</RefSource>
<PMID Version="1">23209328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2009 Dec;124(3):301-8</RefSource>
<PMID Version="1">19788897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2016 May;283(9):1734-47</RefSource>
<PMID Version="1">26936634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 1995 Sep 27;1252(1):28-34</RefSource>
<PMID Version="1">7548163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Mal Infect. 2015 Jul;45(7):243-63</RefSource>
<PMID Version="1">26119684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Exp Immunol. 2003 Jun;132(3):467-72</RefSource>
<PMID Version="1">12780694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2008 Nov 14;29(5):720-33</RefSource>
<PMID Version="1">18951048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2011 Jul 14;118(2):298-308</RefSource>
<PMID Version="1">21411754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2015 Feb;15(2):87-103</RefSource>
<PMID Version="1">25614319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Genomics. 2013 Nov 11;14:778</RefSource>
<PMID Version="1">24215113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Chem. 2014 Feb;395(2):181-202</RefSource>
<PMID Version="1">24002663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Virol. 2014 Aug;86(8):1393-401</RefSource>
<PMID Version="1">24523146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2016 Jan 28;164(3):564-78</RefSource>
<PMID Version="1">26824662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1998 Apr 1;160(7):3610-6</RefSource>
<PMID Version="1">9531325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2015 Jan 15;194(2):678-89</RefSource>
<PMID Version="1">25488988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Med Chem. 2015 ;15(20):2080-114</RefSource>
<PMID Version="1">25986685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2008 Oct;9(10):1091-4</RefSource>
<PMID Version="1">18800157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2014 Dec 6;384(9959):2046-52</RefSource>
<PMID Version="1">25132507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2011 Jan 15;203(2):149-57</RefSource>
<PMID Version="1">21288813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Chem. 2014 Oct;395(10):1253-62</RefSource>
<PMID Version="1">25205732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vector Borne Zoonotic Dis. 2015 Apr;15(4):241-9</RefSource>
<PMID Version="1">25897810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Small. 2010 Aug 16;6(16):1776-84</RefSource>
<PMID Version="1">20665754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Oct;7(10 ):e1002322</RefSource>
<PMID Version="1">22028657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1998 Feb;72(2):1516-22</RefSource>
<PMID Version="1">9445055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2000 Oct;74(20):9802-7</RefSource>
<PMID Version="1">11000258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2012 Dec;122(12):4447-60</RefSource>
<PMID Version="1">23160199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunology. 1991 May;73(1):117-9</RefSource>
<PMID Version="1">2045125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiol Infect. 2012 May;140(5):842-50</RefSource>
<PMID Version="1">21767452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheumatol. 2014 Feb;66(2):319-26</RefSource>
<PMID Version="1">24504804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13950-5</RefSource>
<PMID Version="1">10570179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Allergy Clin Immunol. 2015 Apr;135(4):846-55</RefSource>
<PMID Version="1">25843597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Bioinformatics. 2011 Dec 17;12:480</RefSource>
<PMID Version="1">22177264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2015 Mar;96(Pt 3):580-9</RefSource>
<PMID Version="1">25395592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol Methods. 1991 Dec 15;145(1-2):43-53</RefSource>
<PMID Version="1">1722495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Viral Immunol. 2010 Feb;23(1):113-7</RefSource>
<PMID Version="1">20121409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2012 Mar 01;7(3):562-78</RefSource>
<PMID Version="1">22383036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2015 Jan 15;194(2):491-7</RefSource>
<PMID Version="1">25556251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5974-9</RefSource>
<PMID Version="1">24711407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63</RefSource>
<PMID Version="1">26195744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Rev Immunol. 2016 Sep 2;35(5):434-454</RefSource>
<PMID Version="1">26606328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2013 Sep;94(3):393-8</RefSource>
<PMID Version="1">23709686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2004 Feb 26;32(4):1372-81</RefSource>
<PMID Version="1">14988425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2015 Nov 19;163(5):1095-107</RefSource>
<PMID Version="1">26553503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2012 Dec 20;120(26):5237-46</RefSource>
<PMID Version="1">23149848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2011 Jul;18(7):1112-9</RefSource>
<PMID Version="1">21311565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2003 Jul 1;31(13):3576-9</RefSource>
<PMID Version="1">12824369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Apr 7;434(7034):772-7</RefSource>
<PMID Version="1">15800576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Aug 28;8(8):e72529</RefSource>
<PMID Version="1">24015257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Sep;7(9):e1002268</RefSource>
<PMID Version="1">21966274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Jul 24;8(2):420-9</RefSource>
<PMID Version="1">25017060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2007 Feb 22;356(8):769-71</RefSource>
<PMID Version="1">17314335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheumatol. 2017 Feb;69(2):320-334</RefSource>
<PMID Version="1">27598995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2008 Aug 4;205(8):1739-46</RefSource>
<PMID Version="1">18606855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angiogenesis. 2015 Jul;18(3):347-59</RefSource>
<PMID Version="1">26026674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Exp Immunol. 1999 May;116(2):366-70</RefSource>
<PMID Version="1">10337032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 1986 Jun;67 ( Pt 6):1189-94</RefSource>
<PMID Version="1">3011976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2016 Apr 21;11(4):e0153975</RefSource>
<PMID Version="1">27100888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2013 Jun 15;190(12):6295-302</RefSource>
<PMID Version="1">23670192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2010 Mar;120(3):894-906</RefSource>
<PMID Version="1">20179353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Sep 18;284(38):25569-75</RefSource>
<PMID Version="1">19617629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Transplant. 2008 Mar;8(3):627-36</RefSource>
<PMID Version="1">18294159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Genomics. 2008 Oct 16;9:488</RefSource>
<PMID Version="1">18925949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2015 Oct 08;10(10):e0139481</RefSource>
<PMID Version="1">26447467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2014 Dec 04;8(12):e3354</RefSource>
<PMID Version="1">25474568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2015 Aug;89(15):7955-69</RefSource>
<PMID Version="1">25995257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2012 Sep;86(18):9888-98</RefSource>
<PMID Version="1">22761364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Genet Evol. 2015 Jun;32:401-8</RefSource>
<PMID Version="1">25847693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2008 Jun 1;197(11):1585-93</RefSource>
<PMID Version="1">18433328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2015 Dec;109(12):793-802</RefSource>
<PMID Version="1">26626342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004499</RefSource>
<PMID Version="1">26938618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2000 Feb 15;95(4):1465-72</RefSource>
<PMID Version="1">10666226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Immunol. 2009 Mar;30(3):117-23</RefSource>
<PMID Version="1">19217825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2008 Feb 8;4(2):e29</RefSource>
<PMID Version="1">18282093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2016 Jan 11;213(1):123-38</RefSource>
<PMID Version="1">26694968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8112-6</RefSource>
<PMID Version="1">8058766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2014 Dec 5;13(12):6067-77</RefSource>
<PMID Version="1">25383893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2015 Jun;15(6):388-400</RefSource>
<PMID Version="1">25998963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genome Biol. 2014;15(12):550</RefSource>
<PMID Version="1">25516281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Rev. 2008 Oct;225:27-45</RefSource>
<PMID Version="1">18837774</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065632" MajorTopicYN="N">Chikungunya Fever</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002646" MajorTopicYN="N">Chikungunya virus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>07</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>12</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28207896</ArticleId>
<ArticleId IdType="doi">10.1371/journal.ppat.1006155</ArticleId>
<ArticleId IdType="pii">PPATHOGENS-D-16-01536</ArticleId>
<ArticleId IdType="pmc">PMC5312928</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001138 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001138 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:28207896
   |texte=   RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:28207896" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024